Web Desc
Microbiome: Therapeutic Implications
Organizer(s): Justin L. Sonnenburg, Fergus Shanahan and Suzanne Devkota
Date: October 06 - 10, 2019
Location: INEC Killarney Convention Centre, Killarney, Co. Kerry, Ireland
Supported by the Directors' Fund
For important information on the coronavirus, please click here
Summary of Meeting:
The microbial communities that inhabit the human body are connected to diverse aspects of our health. The plasticity and individuality of these communities promise great potential in the emerging vision of precision health, but formidable gaps to realizing this potential must be addressed. Critical challenges include the intrinsic complexity of dynamic microbial ecosystems, understanding how these microbes mechanistically connect to human biology, and identifying key therapeutic opportunities. This conference will bring together leaders across a range of disciplines from both academia and industry in microbiome sciences to present recent progress and innovative directions at addressing these gaps. This conference will provide a detailed view of the current status, future vision, and challenges of key modalities for predicting, diagnosing, and treating disease via the microbiome. In addition, there will be topics which augment the traditional biomedical paradigm of developing diagnostics and treatments with orthogonal approaches, such as pre-therapeutic prevention and health optimization strategies. Invited speakers will present key technologies and approaches for propelling the coming phases of basic and translational microbiome research. Finally, participants will receive key information about the current regulatory environment for microbial therapeutics. With the rapid expansion of translational microbiome efforts, this conference will enable synergies through the aggregation of knowledge and experiences from diverse body sites, disease states, and approaches. We combine facets of basic sciences including evolution, ecology, and technology development so an interdisciplinary collection of scientists can elucidate key steps for establishing a strong pipeline from fundamental understanding to therapeutic realization.
Scholarship Deadline: June 6 2019
Discounted Abstract Deadline: June 6 2019
Abstract Deadline: July 9 2019
Discounted Registration Deadline: August 7 2019
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.


We gratefully acknowledge additional support from these exhibitors at this conference:
CosmosIDDon Whitley Scientific LimitedMicrobiology International
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI147695-01
Funding for this conference was made possible (in part) by 1R13AI147695-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, October 06 | 4:00PM - 8:00PM
Arrival and Registration
Room: Foyer


Sunday, October 06 | 6:00PM - 8:00PM
Welcome Mixer
Room: Foyer
No registration fees are used to fund alcohol served at this function.

Monday, October 07 | 8:30AM - 9:30AM
Welcome and Keynote Address
Room: Main Auditorium

Speaker 1 of 2
* Fergus Shanahan, National University of Ireland, Ireland

Monday, October 07 | 8:30AM - 9:30AM
Welcome and Keynote Address
Room: Main Auditorium

Speaker 2 of 2
David A. Relman, Stanford University, USA
Humans, History and the Study of Microbiomes: Where Have We Been, Where do We Need to Go?

Monday, October 07 | 9:30AM - 12:00PM
Live Microbial Therapeutics
Room: Main Auditorium

Speaker 1 of 7
* Elena F. Verdu, McMaster University, Canada

Monday, October 07 | 9:30AM - 12:00PM
Live Microbial Therapeutics
Room: Main Auditorium

Speaker 2 of 7
Bernat Olle, Vedanta Biosciences, USA
Medicines Based on Defined Bacterial Consortia

Monday, October 07 | 9:30AM - 12:00PM
Live Microbial Therapeutics
Room: Main Auditorium


Coffee Break

Monday, October 07 | 9:30AM - 12:00PM
Live Microbial Therapeutics
Room: Main Auditorium

Speaker 4 of 7
Ian A. Myles, NIAID, National Institutes of Health, USA
Short Talk: First-in-Human Topical Microbiome Transplantation with Roseomonas Mucosa for Atopic Dermatitis: Clinical Outcomes and Mechanistic Insights

Monday, October 07 | 9:30AM - 12:00PM
Live Microbial Therapeutics
Room: Main Auditorium

Speaker 5 of 7
Alice Cheng, Stanford University, USA
Short Talk: Design and Therapeutic Application of a Highly Complex Synthetic Microbial Community

Monday, October 07 | 9:30AM - 12:00PM
Live Microbial Therapeutics
Room: Main Auditorium

Speaker 6 of 7
Jessica Ravikoff Allegretti, Brigham and Women's Hospital, USA
FMT for C. difficile and Beyond

Monday, October 07 | 9:30AM - 12:00PM
Live Microbial Therapeutics
Room: Main Auditorium

Speaker 7 of 7
Paul E. Carlson, US Food and Drug Administration, USA
Regulatory Considerations for Microbiome Related Products

Monday, October 07 | 12:00PM - 5:00PM
On Own for Lunch


Monday, October 07 | 12:00PM - 1:00PM
Poster Setup
Room: Foyer


Monday, October 07 | 1:00PM - 10:00PM
Poster Viewing
Room: Foyer


Monday, October 07 | 2:30PM - 4:30PM
Workshop 1: Microbiome Science: Human-Centered Studies
Room: Main Auditorium

Speaker 1 of 9
* Tzu-Wen L. Cross, Purdue University, USA

Monday, October 07 | 2:30PM - 4:30PM
Workshop 1: Microbiome Science: Human-Centered Studies
Room: Main Auditorium

Speaker 2 of 9
Michael Woodworth, Emory University School of Medicine, USA
Clearance of Antibiotic-Resistant Enterobacteriaceae after Stool Enema Shown by Genome Sequencing of Stool-Derived and Clinical Isolates

Monday, October 07 | 2:30PM - 4:30PM
Workshop 1: Microbiome Science: Human-Centered Studies
Room: Main Auditorium

Speaker 3 of 9
Jessica McCann, Duke University, USA
Deciphering the Contribution of the Microbiome to Branched Chain Amino Acid (BCAA) Metabolism and Obesity in Adolescents and Mice

Monday, October 07 | 2:30PM - 4:30PM
Workshop 1: Microbiome Science: Human-Centered Studies
Room: Main Auditorium

Speaker 4 of 9
Anubhav Das, 4D Pharma Cork Ltd, Ireland
Impact of a Live Biotherapeutic on the Structure of the Gut Microbiota – Results from the Blautix Phase I Study in Irritable Bowel Syndrome


Monday, October 07 | 2:30PM - 4:30PM
Workshop 1: Microbiome Science: Human-Centered Studies
Room: Main Auditorium

Speaker 5 of 9
Julia Copeland, University of Toronto, Canada
The Impact of Immigration on the Gut Metagenome of South Asian Canadians


Monday, October 07 | 2:30PM - 4:30PM
Workshop 1: Microbiome Science: Human-Centered Studies
Room: Main Auditorium

Speaker 6 of 9
Carles Lerin, Hospital Sant Joan de Deu, Spain
Effects of Bifidobacterium animalis subsp. lactis BPL1 (CECT 8145) on Children with Prader-Willi Syndrome: A Randomized Crossover Trial

Monday, October 07 | 2:30PM - 4:30PM
Workshop 1: Microbiome Science: Human-Centered Studies
Room: Main Auditorium

Speaker 7 of 9
Philippa Margaret Wells, King's College London, UK
Genetic Risk of Rheumatoid Arthritis is Associated with the Oral and Gut Microbiota


Monday, October 07 | 2:30PM - 4:30PM
Workshop 1: Microbiome Science: Human-Centered Studies
Room: Main Auditorium

Speaker 8 of 9
Madelief Wijdeveld, Amsterdam University Medical Center, Netherlands
Relation Between Intestinal Acetate Production and Plasma Glucose Levels in Healthy Subjects

Monday, October 07 | 2:30PM - 4:30PM
Workshop 1: Microbiome Science: Human-Centered Studies
Room: Main Auditorium

Speaker 9 of 9
Christopher B. Ford, Seres Therapeutics, USA
Engraftment of Investigational Microbiome Drug, SER-262, in Subjects Receiving Vancomycin is Associated with Reduced Rates of Recurrence after Primary Clostridium difficile Infection (CDI)

Monday, October 07 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Monday, October 07 | 5:00PM - 7:00PM
Using the Microbiome to Alter Immune Status: Beyond Colonic
Bacteria

Room: Main Auditorium

Speaker 1 of 5
* Justin L. Sonnenburg, Stanford University, USA

Monday, October 07 | 5:00PM - 7:00PM
Using the Microbiome to Alter Immune Status: Beyond Colonic
Bacteria

Room: Main Auditorium

Speaker 2 of 5
David M. Underhill, Cedars-Sinai Medical Center, USA
A Role for the Fungal Microbiota in Crohn’s Disease?

Monday, October 07 | 5:00PM - 7:00PM
Using the Microbiome to Alter Immune Status: Beyond Colonic
Bacteria

Room: Main Auditorium

Speaker 3 of 5
Susan V. Lynch, University of California, San Francisco, USA
Infant Probiotics to Combat Allergies and Asthma

Monday, October 07 | 5:00PM - 7:00PM
Using the Microbiome to Alter Immune Status: Beyond Colonic
Bacteria

Room: Main Auditorium

Speaker 4 of 5
Elena F. Verdu, McMaster University, Canada
Small Intestinal Microbiome and Gluten Metabolism: A Missing Ingredient in Celiac Disease?

Monday, October 07 | 5:00PM - 7:00PM
Using the Microbiome to Alter Immune Status: Beyond Colonic
Bacteria

Room: Main Auditorium

Speaker 5 of 5
David Chaim Jacob Zilber, Noma Restaurant, Denmark
Democratizing Deliciousness

Monday, October 07 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Foyer
No registration fees are used to fund alcohol served at this function.

Monday, October 07 | 7:30PM - 10:00PM
Poster Session 1
Room: Foyer


Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium

Speaker 1 of 10
* Suzanne Devkota, Cedars-Sinai Medical Center, USA

Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium

Speaker 2 of 10
Christopher J. Damman, Bill & Melinda Gates Foundation, USA
Food, Microbes, and the Gut for Good Growth in Global Health

Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium

Speaker 3 of 10
Arjun Raman, Washington University in St. Louis, USA
Short Talk: A Sparse Co-Varying Unit that Describes Healthy and Impaired Community Development

Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium

Speaker 4 of 10
Paul W. O'Toole, University College Cork, Ireland
The Impact of Diet on Microbiome in Aging

Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium


Coffee Break

Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium

Speaker 6 of 10
Brianna Petrone, Duke University, USA
Short Talk: DNA Metabarcoding, a Molecular Diet Survey for Studies of Human Gut Microbiota

Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium

Speaker 7 of 10
Liping Zhao, Shanghai Jiao Tong University, China and Rutgers University, USA
Diets, Microbes and Diabetes

Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium

Speaker 8 of 10
Wenjie Ma, Massachusetts General Hospital, USA
Short Talk: Dietary Fiber Intake, the Gut Microbiome, and Chronic Systemic Inflammation

Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium

Speaker 9 of 10
Ivan Vujkovic-Cvijin, NIAID, National Institutes of Health, USA
Short Talk: Mining Immune Memory to Identify Pro-Inflammatory Gut Microbiota Members in Mice and Humans

Tuesday, October 08 | 8:30AM - 11:45AM
Diet as a Lever for Altering the Microbiome
Room: Main Auditorium

Speaker 10 of 10
Mark Sampson, Azitra Inc., USA
Short Talk: Engineering the Skin Microbiome to Treat Skin Disease: A Phase I First-in-Human Safety Study with Topical Application of Engineered S. Epidermidis


Tuesday, October 08 | 11:45AM - 5:00PM
On Own for Lunch


Tuesday, October 08 | 11:45AM - 1:00PM
Poster Setup
Room: Foyer


Tuesday, October 08 | 1:00PM - 10:00PM
Poster Viewing
Room: Foyer


Tuesday, October 08 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Tuesday, October 08 | 5:00PM - 7:00PM
Controlling Microbial Metabolism
Room: Main Auditorium

Speaker 1 of 6
* David A. Relman, Stanford University, USA

Tuesday, October 08 | 5:00PM - 7:00PM
Controlling Microbial Metabolism
Room: Main Auditorium

Speaker 2 of 6
Eric C. Martens, University of Michigan Medical School, USA
Diet-Induced, Microbial Mucus Erosion as a Catalyst for Intestinal Diseases

Tuesday, October 08 | 5:00PM - 7:00PM
Controlling Microbial Metabolism
Room: Main Auditorium

Speaker 3 of 6
Patricia Wolf, University of Illinois at Urbana-Champaign, USA
Short Talk: Network Modeling of Bile Acid Metabolomics and Cecal Bacterial Metatranscriptomic Responses to Berberine in a Gnotobiotic Mouse Model Constituted with the B4PC2 Human Microbial Consortium

Tuesday, October 08 | 5:00PM - 7:00PM
Controlling Microbial Metabolism
Room: Main Auditorium

Speaker 4 of 6
Weston Whitaker, Novome Biotechnologies, USA
Synthetic Biology for Engineering Gut Microbes

Tuesday, October 08 | 5:00PM - 7:00PM
Controlling Microbial Metabolism
Room: Main Auditorium

Speaker 5 of 6
Gary D. Wu, University of Pennsylvania, USA
Engineering the Environment of the Gut to Modify the Gut Microbiota and its Metabolome

Tuesday, October 08 | 5:00PM - 7:00PM
Controlling Microbial Metabolism
Room: Main Auditorium

Speaker 6 of 6
Will Van Treuren, Stanford University, USA
Short Talk: Strain-Resolved Metabolomics of >150 Human Gut-Resident Bacterial Species Reveals Large-Scale Ecological Patterns, Novel Metabolic Strategies, and Widespread Production of Physiologically Relevant Molecules

Tuesday, October 08 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Foyer
No registration fees are used to fund alcohol served at this function.

Tuesday, October 08 | 7:30PM - 10:00PM
Poster Session 2
Room: Foyer


Wednesday, October 09 | 8:00AM - 8:30AM
Poster Setup
Room: Foyer


Wednesday, October 09 | 8:30AM - 5:00PM
Poster Viewing
Room: Foyer


Wednesday, October 09 | 8:30AM - 11:45AM
Looking to the Past, Predicting the Future
Room: Main Auditorium

Speaker 1 of 9
* Kelly Swanson, University of Illinois at Urbana-Champaign, USA

Wednesday, October 09 | 8:30AM - 11:45AM
Looking to the Past, Predicting the Future
Room: Main Auditorium

Speaker 2 of 9
Justin L. Sonnenburg, Stanford University, USA
Ancestral Microbes and Precision Human Interventions

Wednesday, October 09 | 8:30AM - 11:45AM
Looking to the Past, Predicting the Future
Room: Main Auditorium

Speaker 3 of 9
Marsha C. Wibowo, Harvard Medical School, USA
Short Talk: Reconstruction of Ancient Microbial Genomes from the Human Gut


Wednesday, October 09 | 8:30AM - 11:45AM
Looking to the Past, Predicting the Future
Room: Main Auditorium

Speaker 4 of 9
Nicolai Karcher, University of Trento, Italy
Short Talk: Analysis of 1,321 Eubacterium Rectale Genomes from Metagenomes Unravels Complex Phylogeographic Population Structure and Subspecies Functional Adaptations

Wednesday, October 09 | 8:30AM - 11:45AM
Looking to the Past, Predicting the Future
Room: Main Auditorium


Coffee Break

Wednesday, October 09 | 8:30AM - 11:45AM
Looking to the Past, Predicting the Future
Room: Main Auditorium

Speaker 6 of 9
Susan Bullman, Fred Hutchinson Cancer Research Center, USA
The Tumor Microbiota: A Role in Cancer Progression and Treatment

Wednesday, October 09 | 8:30AM - 11:45AM
Looking to the Past, Predicting the Future
Room: Main Auditorium

Speaker 7 of 9
David Zeevi, Rockefeller University, USA
Structural Variation in the Gut Microbiome Associates with Host Health

Wednesday, October 09 | 8:30AM - 11:45AM
Looking to the Past, Predicting the Future
Room: Main Auditorium

Speaker 8 of 9
Matthew R. Olm, University of California, Berkeley, USA
Short Talk: Metagenomic Identification of Fecal Microbial Signatures Preceding Acute Intestinal Inflammation in Premature Infants

Wednesday, October 09 | 8:30AM - 11:45AM
Looking to the Past, Predicting the Future
Room: Main Auditorium

Speaker 9 of 9
Fergus Shanahan, National University of Ireland, Ireland
Translating Microbiome Science – Lessons from the Past and Future Directions

Wednesday, October 09 | 11:45AM - 12:30PM
Lunch
Room: Foyer


Wednesday, October 09 | 12:00PM - 2:30PM
Poster Session 3
Room: Foyer


Wednesday, October 09 | 2:30PM - 4:30PM
Workshop 2: Considerations for Conducting Human Trials and T
esting Investigational New Drugs
Room: Main Auditorium

Speaker 1 of 6
* Suzanne Devkota, Cedars-Sinai Medical Center, USA

Wednesday, October 09 | 2:30PM - 4:30PM
Workshop 2: Considerations for Conducting Human Trials and T
esting Investigational New Drugs
Room: Main Auditorium

Speaker 2 of 6
Paul E. Carlson, US Food and Drug Administration, USA

Wednesday, October 09 | 2:30PM - 4:30PM
Workshop 2: Considerations for Conducting Human Trials and T
esting Investigational New Drugs
Room: Main Auditorium

Speaker 3 of 6
Susan V. Lynch, University of California, San Francisco, USA

Wednesday, October 09 | 2:30PM - 4:30PM
Workshop 2: Considerations for Conducting Human Trials and T
esting Investigational New Drugs
Room: Main Auditorium

Speaker 4 of 6
Bernat Olle, Vedanta Biosciences, USA

Wednesday, October 09 | 2:30PM - 4:30PM
Workshop 2: Considerations for Conducting Human Trials and T
esting Investigational New Drugs
Room: Main Auditorium

Speaker 5 of 6
Jessica Ravikoff Allegretti, Brigham and Women's Hospital, USA

Wednesday, October 09 | 2:30PM - 4:30PM
Workshop 2: Considerations for Conducting Human Trials and T
esting Investigational New Drugs
Room: Main Auditorium

Speaker 6 of 6
Purna C. Kashyap, Mayo Clinic, USA

Wednesday, October 09 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Wednesday, October 09 | 5:00PM - 7:00PM
Therapeutics - A Whole Body Approach
Room: Main Auditorium

Speaker 1 of 6
* Premysl Bercik, McMaster University, Canada

Wednesday, October 09 | 5:00PM - 7:00PM
Therapeutics - A Whole Body Approach
Room: Main Auditorium

Speaker 2 of 6
Purna C. Kashyap, Mayo Clinic, USA
An Integrated Top Down and Bottom Up Strategy for Delineating the Role of Gut Microbiome in Functional Bowel Disorders

Wednesday, October 09 | 5:00PM - 7:00PM
Therapeutics - A Whole Body Approach
Room: Main Auditorium

Speaker 3 of 6
Hagit Shapiro, Weizmann Institute of Science, Israel
Short Talk: Potential Roles of the Gut Microbiome in Modulation of Murine ALS


Wednesday, October 09 | 5:00PM - 7:00PM
Therapeutics - A Whole Body Approach
Room: Main Auditorium

Speaker 4 of 6
John Cryan, University College Cork, Ireland
Microbes and the Mind: Moving Toward Mechanisms

Wednesday, October 09 | 5:00PM - 7:00PM
Therapeutics - A Whole Body Approach
Room: Main Auditorium

Speaker 5 of 6
Hannah Yan, Baylor College of Medicine, USA
Short Talk: The Bacterial Microbiome Regulates Steady-State Hematopoiesis via Immune Signaling Pathways


Wednesday, October 09 | 5:00PM - 7:00PM
Therapeutics - A Whole Body Approach
Room: Main Auditorium

Speaker 6 of 6
Eileen Murphy, Alimentary Health, Ireland
The Pipeline from Concept to Market - Harnessing the Microbiome for Health

Wednesday, October 09 | 7:00PM - 7:00PM
On Own for Dinner


Thursday, October 10 | 8:30AM - 11:45AM
Antibiotic Resistance, Microbe Killing, and Survival
Room: Main Auditorium

Speaker 1 of 9
* Robert A. Britton, Baylor College of Medicine, USA

Thursday, October 10 | 8:30AM - 11:45AM
Antibiotic Resistance, Microbe Killing, and Survival
Room: Main Auditorium

Speaker 2 of 9
Kevin Foster, University of Oxford, UK
Cooperation and Competition in Bacteria: From Model Systems to the Microbiome

Thursday, October 10 | 8:30AM - 11:45AM
Antibiotic Resistance, Microbe Killing, and Survival
Room: Main Auditorium

Speaker 3 of 9
Daniel C. Propheter, University of Texas Southwestern Medical Center, USA
Short Talk: Adiponectin is a Novel Intestinal Antibacterial Defense Protein


Thursday, October 10 | 8:30AM - 11:45AM
Antibiotic Resistance, Microbe Killing, and Survival
Room: Main Auditorium

Speaker 4 of 9
Suzanne Devkota, Cedars-Sinai Medical Center, USA
Creeping Fat: Microbial Translocation Drives Cellular Restructuring of Adipose Tissue in Humans

Thursday, October 10 | 8:30AM - 11:45AM
Antibiotic Resistance, Microbe Killing, and Survival
Room: Main Auditorium


Coffee Break

Thursday, October 10 | 8:30AM - 11:45AM
Antibiotic Resistance, Microbe Killing, and Survival
Room: Main Auditorium

Speaker 6 of 9
Eric G. Pamer, University of Chicago, USA
Exploiting the Microbiota to Reduce Antibiotic-Resistant Infections

Thursday, October 10 | 8:30AM - 11:45AM
Antibiotic Resistance, Microbe Killing, and Survival
Room: Main Auditorium

Speaker 7 of 9
Sujatha Srinivasan, Fred Hutchinson Cancer Research Center, USA
Short Talk: Periodic Presumptive Treatment (PPT) with Metronidazole Reduces Abundance of Vaginal Bacteria Associated with HIV Risk


Thursday, October 10 | 8:30AM - 11:45AM
Antibiotic Resistance, Microbe Killing, and Survival
Room: Main Auditorium

Speaker 8 of 9
Ami S. Bhatt, Stanford University, USA
Mechanisms of Microbial Diversification and Resistance

Thursday, October 10 | 8:30AM - 11:45AM
Antibiotic Resistance, Microbe Killing, and Survival
Room: Main Auditorium

Speaker 9 of 9
Takuji Yamada, Tokyo Institute of Technology, Japan
Short Talk: Metagenomic and Metabolomic Analyses Reveal Distinct Stage-Specific Phenotypes of the Gut Microbiota in Colorectal Cancer

Thursday, October 10 | 11:45AM - 5:00PM
On Own for Lunch


Thursday, October 10 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Thursday, October 10 | 5:00PM - 6:45PM
Next-Gen Therapeutics and New Frontiers
Room: Main Auditorium

Speaker 1 of 5
* Ami S. Bhatt, Stanford University, USA

Thursday, October 10 | 5:00PM - 6:45PM
Next-Gen Therapeutics and New Frontiers
Room: Main Auditorium

Speaker 2 of 5
Jeff F. Miller, University of California, Los Angeles, USA
Diversity-Generating Retroelements in Phage, Microbes, and Microbiomes

Thursday, October 10 | 5:00PM - 6:45PM
Next-Gen Therapeutics and New Frontiers
Room: Main Auditorium

Speaker 3 of 5
Ines Thiele, National University of Ireland, Galway, Ireland
Modeling Gut Microbiome Metabolism

Thursday, October 10 | 5:00PM - 6:45PM
Next-Gen Therapeutics and New Frontiers
Room: Main Auditorium

Speaker 4 of 5
Ravi U. Sheth, Columbia University, USA
Short Talk: Spatial Metagenomic Characterization of Microbial Biogeography in the Gut


Thursday, October 10 | 5:00PM - 6:45PM
Next-Gen Therapeutics and New Frontiers
Room: Main Auditorium

Speaker 5 of 5
Trevor Lawley, Wellcome Sanger Institute, UK
Integrating Mass Culturing and Metagenomic Analysis for Human Microbiome Translational Science

Thursday, October 10 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Main Auditorium


Thursday, October 10 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Foyer
No registration fees are used to fund alcohol served at this function.

Thursday, October 10 | 8:00PM - 11:00PM
Entertainment
Room: Foyer
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Friday, October 11 | 10:24AM - 10:24AM
Departure


*Session Chair
†Invited, not yet responded.